Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Edorado Elia"'
Autor:
Aldo Bonaventura, Federica Biello, Franco Dallegri, Daniele Ferrara, Fabrizio Montecucco, Marco Tagliamento, Giovanni Rossi, Nicholas Bardi, Carlo Genova, E. Rijavec, Simona Coco, Anna Maria Ansaldo, A. Alama, Paolo Spallarossa, Federico Carbone, Francesco Grossi, M.G. Dal Bello, Alessandra Vecchié, Silvia Minetti, Edorado Elia
Publikováno v:
Clinicaltranslational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 22(9)
Since the role of resistin was evaluated only in patients with non-small cell lung cancer (NSCLC) not treated with immunotherapy, we aimed to evaluate levels of resistin during immunotherapy (nivolumab) and its prognostic role with regard to OS. From
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2459484b8ed410af79ef8ec5178755e4
https://pubmed.ncbi.nlm.nih.gov/32048158
https://pubmed.ncbi.nlm.nih.gov/32048158
Autor:
Silvia Minetti, Nathan Artom, Daniela Verzola, Roberto Pontremoli, Aldo Bonaventura, Giorgio Luciano Viviani, Franco Dallegri, Luca Liberale, Federico Carbone, Matteo Casula, Livia Pisciotta, Maria Bertolotto, Franesca Viazzi, Fabrizio Montecucco, Paola Contini, Stefano Bertolini, Aldo Pende, Edorado Elia
BACKGROUND Inflammation, overweight and other cardiovascular risk factors might negatively impact on hypertension remission in metabolic syndrome (MetS), independently of the pharmacological treatment. Here, the potential influence of systemic inflam
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3533ca59d8ced78500c84317432b9162
http://hdl.handle.net/11567/945304
http://hdl.handle.net/11567/945304
